The conditional role of inflammation in pregnancy and cancer

Clinical Nutrition

Volumn 32, Issue 3, 2013, Pages 460-465

  Soeters, Peter B ^a   Grimble, Robert F ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Anti rejection effects; Arginase; Cancer; Cell proliferation; Fetal growth; Inflammation; Th1 Th2 ratio

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; NITRIC OXIDE; PIOGLITAZONE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME REGULATION; FETUS GROWTH; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHYSIOLOGY; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TH1 TH2 BALANCE; TROPHOBLAST;

CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; NEOPLASMS; NITRIC OXIDE; PREGNANCY; TH1-TH2 BALANCE; TRANSFORMING GROWTH FACTOR BETA; TROPHOBLASTS;

EID: 84877151832     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.07.010     Document Type: Article

References (63)

1. Yang L. TGFbeta and cancer metastasis: an inflammation link. Cancer Metastasis Rev 2010, 29:263-271.
2. Yang L., Pang Y., Moses H.L. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 2010, 31:220-227.
3. Soeters P.B., Grimble R.F. Dangers, and benefits of the cytokine mediated response to injury and infection. Clin Nutr 2009, 28(6):583-596.
4. Kohl B.A., Deutschman C.S. The inflammatory response to surgery and trauma. Curr Opin Crit Care 2006, 12:325-332.
5. Calfee C.S., Matthay M.A. Clinical immunology: culprits with evolutionary ties. Nature 2010, 464:41-42.
6. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464(7285):104-107.
7. Deutz N.E., Reijven P.L., Athanasas G., Soeters P.B. Post-operative changes in hepatic, intestinal, splenic and muscle fluxes of amino acids and ammonia in pigs. Clin Sci (Lond) 1992, 83:607-614.
8. Broughton G., Janis J.E., Attinger C.E. The basic science of wound healing. Plast Reconstr Surg 2006, 117:12S-34S.
9. Salcido R.S. Do anti-inflammatories have a role in wound healing?. Adv Skin Wound Care 2005, 18:65-66.
10. Mikaeloff Y., Kezouh A., Suissa S. Nonsteroidal anti-inflammatory drug use and the risk of severe skin and soft tissue complications in patients with varicella or zoster disease 2008, p. 203-9.
11. Souyri C., Olivier P., Grolleau S., Lapeyre-Mestre M. Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol 2008, 33:249-255.
12. Fries J.F., Williams C.A., Bloch D.A., Michel B.A. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991, 91:213-222.
13. Smalley W.E., Ray W.A., Daugherty J.R., Griffin M.R. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995, 141:539-545.
14. Pountos I., Georgouli T., Blokhuis T.J., Pape H.C., Giannoudis P.V. Pharmacological agents and impairment of fracture healing: what is the evidence?. Injury 2008, 39:384-394.
15. Kristensen DMb, Hass U., Lesné L., Lottrup G., Jacobsen P.R., Desdoits-Lethimonier C., et al. Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod 2010, 26:235-244.
16. Bolpetti A., Silva J.S., Villa L.L., Lepique A.P. Interleukin-10 production by tumor infiltrating macrophages plays a role in human papillomavirus 16 tumor growth. BMC Immunol 2010, 11:27.
17. Jarnicki A.G., Lysaght J., Todryk S., Mills K.H. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 2006, 177:896-904.
18. Wilke C., Wei S., Wang L., Kryczek I., Kao J., Zou W. Dual biological effects of the cytokines interleukin-10 and interferon-γ. Cancer Immunol Immunother 2011, 60:1529-1541.
19. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003, 8:223-246.
20. Sharda D.R., Yu S., Ray M., Squadrito M.L., De Palma M., Wynn T.A., et al. Regulation of macrophage arginase expression and tumor growth by the Ron receptor tyrosine kinase. J Immunol 2011, 187(5):2181-2192.
21. Li H., Sorenson A.L., Poczobutt J., Amin J., Joyal T., Sullivan T., et al. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis. PLoS ONE 2011, 6(12):e28133.
22. Calleja-Agius J., Jauniaux E., Pizzey A.R., Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 2012, 27:349-357.
23. Redman C.W., Sargent I.L. Immunology of pre-eclampsia. Am J Reprod Immunol 2010, 63:534-543.
24. Calleja-Agius J., Muttukrishna S., Pizzey A.R., Jauniaux E. Pro- and antiinflammatory cytokines in threatened miscarriages. Am J Obstet Gynecol 2011, 205(83):e8-16.
25. Fan D.-X., Duan J., Li M.-Q., Xu B., Li D.-J., Jin L.-P. The decidual gamma-delta T cells up-regulate the biological functions of trophoblasts via IL-10 secretion in early human pregnancy. Clin Immunol 2011, 141:284-292.
26. Giannubilo S.R., Landi B., Pozzi V., Sartini D., Cecati M., Stortoni P., et al. The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. Cytokine 2012, 58(1):50-56.
27. Lafontaine L., Chaudhry P., Lafleur M.J., Van Themsche C., Soares M.J., Asselin E. Transforming growth factor beta regulates proliferation and invasion of rat placental cell lines. Biol Reprod 2011, 84:553-559.
28. Soeters P.B. Plasma albumin: a confusing nutritional measure. Nutrition 1990, 6:267.
29. Soeters P.B. Rationale for albumin infusions. Curr Opin Clin Nutr Metab Care 2009, 12:258-264.
30. Ishikawa T., Harada T., Koi H., Kubota T., Azuma H., Aso T. Identification of arginase in human placental villi. Placenta 2007, 28:133-138.
31. Kropf P., Baud D., Marshall S.E., Munder M., Mosley A., Fuentes J.M., et al. Arginase activity mediates reversible T cell hyporesponsiveness in human pregnancy. Eur J Immunol 2007, 37(4):935-945.
32. Winger E.E., Reed J.L. Low circulating CD4+ CD25+ Foxp3+ T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure. Am J Reprod Immunol 2011, 66:320-328.
33. Peterson R.A. Regulatory T-Cells: diverse phenotypes integral to immune homeostasis and suppression. Toxicol Pathol 2012, 40:186-204.
34. Gude N.M., Roberts C.T., Kalionis B., King R.G. Growth and function of the normal human placenta. Thromb Res 2004, 114:397-407.
35. Johansson A.L.V., Andersson T.M.-L., Hsieh C.-C., Cnattingius S., Lambe M. Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomark Prev 2011, 20:1865-1872.
36. Moreira W.B., Brandão E.C., Soares A.N., Lucena CcEMd, Antunes CMcF. Prognosis for patients diagnosed with pregnancy-associated breast cancer: a paired case-control study. Sao Paulo Med J 2010, 128:119-124.
37. Slingluff C.L., Seigler H.F. Malignant melanoma and pregnancy. Ann Plast Surg 1992, 28:95-99.
38. Argubright K.F., Mattox J.H., Messer R.H. Thymoma in pregnancy. Obstet Gynecol Surv 1984, 39:185-191.
39. Rowe Jared H., Ertelt James M., Aguilera Marijo N., Farrar Michael A., Way Sing S. Foxp3+ regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 2011, 10:54-64.
40. Hunnewell M.G., Forbes N.S. Active and inactive metabolic pathways in tumor spheroids: determination by GC-MS. Biotechnol Prog 2010, 26:789-796.
41. Emre Y., Nübel T. Uncoupling protein UCP2: when mitochondrial activity meets immunity. FEBS Lett 2010, 584:1437-1442.
42. Self J.T., Spencer T.E., Johnson G.A., Hu J., Bazer F.W., Wu G. Glutamine synthesis in the developing porcine placenta. Biol Reprod 2004, 70:1444-1451.
43. Levine A.J., Puzio-Kuter A.M. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 2010, 330:1340-1344.
44. Holla V.R., Wu H., Shi Q., Menter D.G., DuBois R.N. Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer. J Biol Chem 2011, 286:30003-30009.
45. Barger J.F., Plas D.R. Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis. Endocr Relat Cancer 2010, 17:R287-R304.
46. Ghio A., Bertolotto A., Resi V., Volpe L., Di Cianni G. Triglyceride metabolism in pregnancy. Adv Clin Chem 2011, 55:133-153.
47. Calder P.C. Fuel utilization by cells of the immune system. Proc Nutr Soc 1995, 54:65-82.
48. Weinberg F., Hamanaka R., Wheaton W.W., Weinberg S., Joseph J., Lopez M., et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci 2010, 107(19):8788-8793.
49. Oey N.A., den Boer M.E., Wijburg F.A., Vekemans M., Auge J., Steiner C., et al. Long-chain fatty acid oxidation during early human development. Pediatr Res 2005, 57(6):755-759.
50. Strauss A.W. Surprising? Perhaps not. Long-chain fatty acid oxidation during human fetal development. Pediatr Res 2005, 57:753-754.
51. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000, 54(Suppl. 1):S47-S51.
52. Herrera E., Amusquivar E., Lopez-Soldado I., Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res Paediatrics 2006, 65:59-64.
53. Abdulhadi N.H. Glucose 6 phosphate dehydrogenase (G6PD) deficiency is a possible risk factor for the development of preeclampsia. Med Hypotheses 2004, 62:780-782.
54. Dheen S.T., Tay S.S., Boran J., Ting L.W., Kumar S.D., Fu J., et al. Recent studies on neural tube defects in embryos of diabetic pregnancy: an overview. Curr Med Chem 2009, 16(18):2345-2354.
55. Hunter E.S., Sadler T.W. Fuel-mediated teratogenesis: biochemical effects of hypoglycemia during neurulation in mouse embryos in vitro. Am J Physiol 1989, 257:E269-E276.
56. Kuznetsova V.A., Slobodin V.B., Moreva I.V., Sitnikova O.G. Role of disorders of pentosephosphate pathway of glucose oxidation in the pathogenesis of the arrest of fetal development in miscarriage. Akush Ginekol (Mosk) 1989, 36-38.
57. Buchakjian M.R., Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol 2010, 11:715-727.
58. Cascante M., Benito A., Zanuy M., Vizan P., Marin S., de Atauri P. Metabolic network adaptations in cancer as targets for novel therapies. Biochem Soc Trans 2010, 38:1302-1306.
59. Feron O. Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. Radiother Oncology: J Eur Soc Ther Radiol Oncol 2009, 92:329-333.
60. Lu X., Bennet B., Mu E., Rabinowitz J., Kang Y. Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model. J Biol Chem 2010, 285:9317-9321.
61. Resendis-Antonio O., Checa A., Encarnación S. Modeling core metabolism in cancer cells: surveying the topology underlying the Warburg effect. PLoS ONE 2010, 5:e12383.
62. Tong X., Zhao F., Thompson C.B. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 2009, 19:32-37.
63. Warburg O., Wind F., Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927, 8:519-530.